Cresco Labs Announces New Board Members

1000 1000 admin

Cresco Labs Announces New Board Members

John R. Walter, PH.D, Tom Manning, and Gerry Corcoran join this market-leading team.

MARCH, 2017 – Cresco Labs, Illinois’ largest Medical Cannabis Brand, announces the addition of three new members to their board of directors:

John R. Walter, PH.D: Former Chairman and Chief Executive Officer, AT&T Corporation and RR Donnelly & Sons Company, Current Chairman & CEO, Ashlin Management Company

Tom Manning: Lead Director, Dun & Bradstreet, Former Senior Partner, Bain & Company, Current Board Director, Advisor and Lecturer, University of Chicago Law School

Gerry Corcoran: Chairman and CEO, R.J. O’Brien & Associates, LLC, and Chairman, Futures Industry Association

The company is dedicated to leading the cannabis industry’s national agenda with solid business strategies and professionalism. By bringing in three executives with experience at the highest levels of business management, the company will further legitimize the category. Co-Founder and CEO, Charles Bachtell says, “We’re building out an exciting company within a landscape that is changing rapidly every day. As a CEO, having a strong, seasoned board is exactly the kind of support I’m looking for.”

Mr. Manning, Mr. Corcoran and Dr. Walter bring an impressive portfolio of expertise from the world’s best companies. They all have proven records of driving and advising companies to reach the top of their industries. “Cresco Labs is strengthened by these new members. We will draw on their expertise to establish operations in the northeast and southwest United States and to execute our international strategic plan.” said Brian McCormack, Co-Founder and Board of Directors Vice-Chairman.

Biographies and details regarding the vast background of Mr. Manning, Mr. Corcoran and Dr. Walter can be found in the addendum.

Although Cresco Labs is moving aggressively towards expansion, they continually work to support their home community in Illinois with outreach and educational efforts and to provide relief to Illinois patients.

Contact:
Cresco Labs
312.488.4712
press@crescolabs.com